Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

In the late 1800s, the U.S. railroad system didn’t just revolutionize transportation—it catalyzed entirely new industries. Refrigerated railcars enabled a national meatpacking economy. Standard time ...

Data is the life-blood of physical AI. Collecting real-life data is expensive. Generative AI and diffusion to create ...

Venetoclax shows similar efficacy and safety in real-world settings and clinical trials for CLL treatment, with a 94% overall response rate. Real-world studies provide insights into diverse patient ...

The European Medicines Agency (EMA) uses Data Analysis and Real-World Interrogation Network (DARWIN EU), a data network that became fully operational in 2024, to generate real-world evidence on ...

Lisocabtagene maraleucel (liso-cel) shows high response rates in heavily pretreated patients with relapsed or refractory chronic lymphocytic leukemia (CLL), with a CR/CRu rate of 60% and ORR of 83.3%.

Inovalon, a leading provider of data and solutions empowering data-driven healthcare, announced its real-world data and analytics supported Forbes’ inaugural Top Hospitals List & Ratings, released ...

How would it cost to charge up your EV if you added a home solar system to your roof? The real-world data might surprise you!

Physician-assessed confirmed ORR reached 44% (18/41) with 73% disease control, suggesting robust activity in checkpoint- and targeted-refractory advanced melanoma. Comparative context showed higher ...